Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.16 USD
Change Today -0.005 / -3.12%
Volume 17.1K
BKYI On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

bio-key international inc (BKYI) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/6/15 - $0.50
52 Week Low
05/8/15 - $0.12
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

bio-key international inc (BKYI) Related Bloomberg News

View More Bloomberg News

bio-key international inc (BKYI) Related Businessweek News

No Related Businessweek News Found

bio-key international inc (BKYI) Details

BIO-key International, Inc. develops and markets fingerprint biometric identification and identity verification technologies, cryptographic authentication-transaction security technologies, and related identity management and credentialing software solutions. Its solutions enable application developers, value added resellers, and channel partners to integrate fingerprint biometrics into their application. The company’s products include Vector Segment Technology SDK, a biometric software development kit that provides developers the ability to incorporate its biometric capabilities into their respective product offerings or infrastructure; Intelligent Image Indexing, a biometric identification solution that offers one-to-many user identifications; and Biometric Service Provider, which provides support for the BioAPI for a compliant interface to applications using biometrics for verification and identification. Its products also comprise ID Director, a solution for single sign on integration with CA Technologies SiteMinder, Oracle’s Fusion Middleware SSO, IBM Tivoli Access Manager, and other solutions; and WEB-key, an authentication-transaction security technology to conduct identification and identity verification transactions in insecure environments, such as the world wide Web or off-site cloud environments. It also sells third-party hardware components. The company markets its products through its direct sales force of professionals, as well as through resellers, integrators, and partner networks to government and corporate customers primarily in North America. The company was formerly known as SAC Technologies, Inc. and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.

18 Employees
Last Reported Date: 05/4/15
Founded in 1993

bio-key international inc (BKYI) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $250.0K
Chief Financial Officer
Total Annual Compensation: $144.0K
Chief Technology Officer
Total Annual Compensation: $192.9K
Vice President of Marketing
Total Annual Compensation: $144.3K
Compensation as of Fiscal Year 2014.

bio-key international inc (BKYI) Key Developments

BIO-key International, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Provides Financial Guidance for the Third Quarter and Reaffirms Financial Guidance for the Full Year of 2015

BIO-key International, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported revenues of $2,272,804 against $402,789 a year ago. Operating profit was $753,550 against operating loss of $1,124,497 a year ago. Net profit was $753,146 or 0.01 per basic and diluted share against net loss of $1,026,286 or 0.02 per basic and diluted share a year ago. For the six months, the company reported revenues of $2,921,630 against $1,770,311 a year ago. Operating loss was $184,302 against $1,217,852 a year ago. Net loss was $170,957 against $1,325,500 a year ago. Basic and diluted loss per share was $0.00 against $0.02 a year ago. Net cash used for operating activities was $505,599 against $1,350,089 for the same period a year ago. Capital expenditures were $2,078 against $5,501 for the same period a year ago. The company remains on track to achieve its full year 2015 revenue guidance range of $5.0 million to $7.0 million, compared to revenue of $4.0 million in 2014. The company's 2015 year-to-date revenue is tracking to the midpoint of its full year guidance range. Gross margin is expected to range between 80%. The company currently expects its third quarter 2015 revenue to range between $700,000 and $1.5 million, versus $1.3 million in third quarter of 2014. Gross margin is expected to range between 75%.

BIO-key International, Inc. to Report Q2, 2015 Results on Aug 14, 2015

BIO-key International, Inc. announced that they will report Q2, 2015 results on Aug 14, 2015

BIO-key International, Inc., Q2 2015 Earnings Call, Aug 14, 2015

BIO-key International, Inc., Q2 2015 Earnings Call, Aug 14, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BKYI:US $0.16 USD -0.005

BKYI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
NEC Corp ¥380.00 JPY +8.00
View Industry Companies

Industry Analysis


Industry Average

Valuation BKYI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.0x
Price/Book 13.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIO-KEY INTERNATIONAL INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at